RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Bacterial Lung Diseases
Accession: DOID:9008559
browse the term
Definition: Pulmonary diseases caused by bacterial infections.
Synonyms: primary_id: RDO:9002453
G
Cxcl15
C-X-C motif chemokine ligand 15
severity
ISO
protein:increased expression:nasal mucus (human)
RGD
PMID:24211414
RGD:40925940
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Marco
macrophage receptor with collagenous structure
disease_progression
IMP
association with Cryptococcal neoformans infection.
RGD
PMID:28298522
RGD:41412191
NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753
G
Ace
angiotensin I converting enzyme
ISO
associated with Cerebrovascular Accident
RGD
PMID:14990394
RGD:4140926
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
RGD
PMID:19515386
RGD:4891456
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
RGD
PMID:19515386
RGD:4891456
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Edn1
endothelin 1
ISO
protein:increased secretion:plasma (rat)
RGD
PMID:19262391
RGD:4145069
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15607125
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Abcc1
ATP-binding cassette, sub-family C member 1
IMP
RGD
PMID:11238654
RGD:5128828
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Ace2
angiotensin converting enzyme 2
IEP
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse)
RGD
PMID:31645418
RGD:40818279
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Ager
advanced glycosylation end product-specific receptor
severity
IAGP
RGD
PMID:21629785
RGD:6767559
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
C3
complement component 3
IMP
RGD
PMID:16014897
RGD:5129508
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C3ar1
complement component 3a receptor 1
IMP
RGD
PMID:16461429
RGD:5129690
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
G
Cat
catalase
ISO
RGD
PMID:19842849
RGD:5130748
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl19
C-C motif chemokine ligand 19
IEP
mRNA, protein:increased expression:lung
RGD
PMID:20176793
RGD:5130918
NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577
G
Ccl2
C-C motif chemokine ligand 2
IMP
RGD
PMID:20042590
RGD:4891443
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl4
C-C motif chemokine ligand 4
IEP
RGD
PMID:20483921
RGD:5130905
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccr2
C-C motif chemokine receptor 2
IMP
RGD
PMID:20042590
RGD:4891443
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr7
C-C motif chemokine receptor 7
IMP
RGD
PMID:20176793
RGD:5130918
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
G
Cd14
CD14 antigen
IMP
RGD
PMID:16210672
RGD:4144197
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
IEP
RGD
PMID:20102413
RGD:5132268
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd80
CD80 antigen
IEP
RGD
PMID:20949109
RGD:4892562
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
Chuk
conserved helix-loop-helix ubiquitous kinase
IEP
RGD
PMID:18643924
RGD:5133701
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
G
Csf3
colony stimulating factor 3 (granulocyte)
disease_progression treatment
ISO
associated with Peritonitis;
RGD
PMID:21373266 PMID:12352049
RGD:5133733 , RGD:11039437
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Csf3r
colony stimulating factor 3 receptor
disease_progression
IMP
RGD
PMID:17185469
RGD:5133739
NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP ISO
RGD
PMID:21723409 PMID:11052817
RGD:5135062 , RGD:5135234
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
IMP IEP
RGD
PMID:16299319 PMID:15618188
RGD:5135458 , RGD:5135459
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl11
chemokine (C-X-C motif) ligand 11
IEP
RGD
PMID:15618188
RGD:5135459
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
G
Cxcl2
C-X-C motif chemokine ligand 2
severity
IEP ISO
RGD
PMID:21723409 PMID:11052817 PMID:19239431
RGD:5135062 , RGD:5135234 , RGD:5135065
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
RGD
PMID:11052817
RGD:5135234
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
RGD
PMID:19846873
RGD:4145490
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcl9
C-X-C motif chemokine ligand 9
IEP
RGD
PMID:15618188
RGD:5135459
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr3
C-X-C motif chemokine receptor 3
IMP
RGD
PMID:15618188
RGD:5135459
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
G
Cyp2j6
cytochrome P450, family 2, subfamily j, polypeptide 6
ISO
protein:decreased expression:lung
RGD
PMID:14766666
RGD:1625385
NCBI chr 4:96,404,375...96,449,835
Ensembl chr 4:96,404,375...96,441,898
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
ISO
protein:decreased expression:lung
RGD
PMID:14766666
RGD:1625385
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Defb3
defensin beta 3
ISO
protein:increased expression:plasma
RGD
PMID:10213993
RGD:4892266
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
G
Defb4
defensin beta 4
ISO
protein:increased expression:plasma
RGD
PMID:10213993
RGD:4892266
NCBI chr 8:19,248,720...19,251,563
Ensembl chr 8:19,248,722...19,251,561
G
F2
coagulation factor II
ISO
RGD
PMID:21897338
RGD:6893486
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fcgr3
Fc receptor, IgG, low affinity III
IMP
RGD
PMID:17975174
RGD:5129707
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Foxp3
forkhead box P3
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gp1ba
glycoprotein 1b, alpha polypeptide
exacerbates
IMP
associated with Escherichia Coli Infections
RGD
PMID:27845343
RGD:42722624
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
G
Grk2
G protein-coupled receptor kinase 2
ISO
mRNA:decreased expression:polymorphonuclear leukocyte
RGD
PMID:24465168
RGD:126848796
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Hc
hemolytic complement
IMP
RGD
PMID:17975174
RGD:5129707
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Icam1
intercellular adhesion molecule 1
IEP
protein:increased expression:lung (mouse)
RGD
PMID:19846873
RGD:4145490
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifnar1
interferon (alpha and beta) receptor 1
severity
IMP
RGD
PMID:19487810
RGD:5490274
NCBI chr16:91,281,016...91,307,411
Ensembl chr16:91,282,126...91,304,329
G
Ifng
interferon gamma
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il10
interleukin 10
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il15
interleukin 15
IMP
RGD
PMID:17911627
RGD:5000754
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Il17a
interleukin 17A
severity
IMP IEP
RGD
PMID:18802100 PMID:25398094
RGD:4889153 , RGD:38501102
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
IMP
RGD
PMID:17664259
RGD:4889913
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
severity treatment
IMP IEP ISO
associated with Agranulocytosis
RGD
PMID:18596024 PMID:25398094 PMID:7546648
RGD:4143205 , RGD:38501102 , RGD:10755357
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
treatment
IMP ISO
associated with Sepsis associated with Acinetobacter infectious disease
RGD
PMID:20959556 PMID:29508184
RGD:5144223 , RGD:40818077
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il1rn
interleukin 1 receptor antagonist
IMP
RGD
PMID:18322242 PMID:18596024
RGD:4143206 , RGD:4143205
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il22
interleukin 22
IMP
RGD
PMID:21178015
RGD:5147404
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
G
Il6
interleukin 6
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak3
interleukin-1 receptor-associated kinase 3
IMP
RGD
PMID:28120642 PMID:20439918
RGD:34888234 , RGD:36049799
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Irf1
interferon regulatory factor 1
IMP
RGD
PMID:11854220
RGD:5128725
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
G
Irf3
interferon regulatory factor 3
IMP
RGD
PMID:20720199
RGD:4891951
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
G
Itgb3
integrin beta 3
ISO
protein:increased expression:lung, neutrophil
RGD
PMID:15114484
RGD:4993468
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Lep
leptin
IMP
RGD
PMID:11937559
RGD:5128871
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Mapk8
mitogen-activated protein kinase 8
severity
IMP
associated with Escherichia Coli Infections
RGD
PMID:22514650
RGD:150340681
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mbl2
mannose-binding lectin (protein C) 2
ISO
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human)
RGD
PMID:18641104
RGD:4889477
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mc1r
melanocortin 1 receptor
IMP
RGD
PMID:18304533
RGD:5687324
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
G
Mmp9
matrix metallopeptidase 9
IMP ISO
protein:increased expression:bronchoalveolar lavage fluid
RGD
PMID:17202364 PMID:19535150
RGD:5130727 , RGD:5129533
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
ISO
protein:increased activity:bronchoalveolar lavage Fluid:
RGD
PMID:11269653
RGD:5130992
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Nod1
nucleotide-binding oligomerization domain containing 1
IMP
RGD
PMID:19360122
RGD:5131449
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
G
Nod2
nucleotide-binding oligomerization domain containing 2
IMP
RGD
PMID:19360122
RGD:5131449
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Pdpn
podoplanin
ISO
protein:increased expression:lung
RGD
PMID:7864138
RGD:2292375
NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134
G
Pecam1
platelet/endothelial cell adhesion molecule 1
ISO
protein:decreased expression:lung
RGD
PMID:12524254
RGD:724645
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pgf
placental growth factor
IEP
protein:increased expression:plasma
RGD
PMID:16702604
RGD:6483601
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pten
phosphatase and tensin homolog
ameliorates
IMP
myeloid knockout
RGD
PMID:21527775
RGD:127285594
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ripk3
receptor-interacting serine-threonine kinase 3
ameliorates
IMP
RGD
PMID:28387756
RGD:127229944
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
G
Rorc
RAR-related orphan receptor gamma
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
severity
IMP
RGD
PMID:17032919
RGD:4144840
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Sftpa1
surfactant associated protein A1
ISO
protein:increased expression:lung
RGD
PMID:12169586
RGD:4143464
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
G
Sftpb
surfactant associated protein B
ISO
associated with Cystic Fibrosis;protein:increased expression:lung
RGD
PMID:15271694 PMID:12169586
RGD:4143403 , RGD:4143464
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Sftpc
surfactant associated protein C
IMP ISO
RGD
PMID:18566429 PMID:12169586
RGD:4144114 , RGD:4143464
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
G
Sftpd
surfactant associated protein D
ISO
associated with Cystic Fibrosis;protein:decreased expression:lung protein:increased expression:lung
RGD
PMID:15271694 PMID:12169586
RGD:4143403 , RGD:4143464
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
G
Stat3
signal transducer and activator of transcription 3
IMP
RGD
PMID:18192501
RGD:6892945
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Tgfb1
transforming growth factor, beta 1
severity
IEP
RGD
PMID:25398094
RGD:38501102
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tlr2
toll-like receptor 2
IMP ISO
RGD
PMID:18768871 PMID:19844782
RGD:4145337 , RGD:4889533
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
IMP
RGD
PMID:16210672 PMID:20650991
RGD:4144197 , RGD:4144172
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr5
toll-like receptor 5
IMP
RGD
PMID:19801452
RGD:5129503
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
G
Tlr6
toll-like receptor 6
ISO
RGD
PMID:19844782
RGD:4889533
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
G
Tlr9
toll-like receptor 9
IMP
RGD
PMID:20360853
RGD:5130719
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
disease_progression treatment severity
ISO IMP
associated with Agranulocytosis
RGD
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055
RGD:4143476 , RGD:10755357 , RGD:10450564 , RGD:10449451
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
IEP
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
IEP
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Trem1
triggering receptor expressed on myeloid cells 1
severity ameliorates
ISO
RGD
PMID:24465168 PMID:16960786 PMID:22996209
RGD:126848796 , RGD:127229902 , RGD:126925987
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Zc3h12a
zinc finger CCCH type containing 12A
IMP
associated with Pseudomonas Infections
RGD
PMID:29695841
RGD:39938967
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
G
Cd274
CD274 antigen
IEP
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Pdcd1
programmed cell death 1
IEP
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
severity
IMP
RGD
PMID:29893841
RGD:40890270
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
G
Cxcl15
C-X-C motif chemokine ligand 15
IMP
RGD
PMID:11207292
RGD:38549344
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Il23a
interleukin 23, alpha subunit p19
severity
IMP
RGD
PMID:16157683
RGD:39457940
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
G
Irak3
interleukin-1 receptor-associated kinase 3
severity
IMP IEP
mRNA:increased expression:lung (mouse)
RGD
PMID:22729155 PMID:20864681
RGD:35316077 , RGD:36049798
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Lcn2
lipocalin 2
exacerbates ameliorates
IMP IGI IEP
protein:increased expression:lung protein:increased expression:serum
RGD
PMID:29633303 PMID:19342674 PMID:19342674 PMID:19342674 PMID:25234944 PMID:25234944 More...
RGD:126725082 , RGD:126725085 , RGD:126725085 , RGD:126725085 , RGD:126725084 , RGD:126725084
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Plac8
placenta-specific 8
severity
IMP
RGD
PMID:17404296
RGD:40924563
NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111
G
Trem1
triggering receptor expressed on myeloid cells 1
disease_progression
IMP
RGD
PMID:24396044
RGD:126925976
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Ada
adenosine deaminase
ISO
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IMP
RGD
PMID:16113250
RGD:4891897
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP
RGD
PMID:11254553
RGD:5135252
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11349020
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il18
interleukin 18
IDA
RGD
PMID:11083766
RGD:4889865
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Mbl2
mannose-binding lectin (protein C) 2
susceptibility
ISO
RGD
PMID:19073229
RGD:12910934
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Nod1
nucleotide-binding oligomerization domain containing 1
IMP
RGD
PMID:20685341
RGD:5131443
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
G
Nod2
nucleotide-binding oligomerization domain containing 2
IMP
RGD
PMID:20685341
RGD:5131443
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Tlr5
toll-like receptor 5
susceptibility
ISO IMP
DNA:nonsense mutation:cds:p.R392X (human) ClinVar Annotator: match by term: Legionnaire disease, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:14623910 PMID:16027372 PMID:23447684 PMID:14623910 PMID:17982089
RGD:5129477 , RGD:5129510
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
G
Tlr9
toll-like receptor 9
IMP
RGD
PMID:18426877
RGD:5130707
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
IMP
RGD
PMID:18838275
RGD:5131445
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
IMP
RGD
PMID:18838275
RGD:5131445
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Ada
adenosine deaminase
ISO
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Atp1b2
ATPase, Na+/K+ transporting, beta 2 polypeptide
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768
G
Ccl4
C-C motif chemokine ligand 4
IEP
RGD
PMID:16988274
RGD:4892091
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccl5
C-C motif chemokine ligand 5
IEP
protein:increased secretion:lung, secretion (mouse)
RGD
PMID:18717637
RGD:4891914
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccl8
C-C motif chemokine ligand 8
IEP
RGD
PMID:16988274
RGD:4892091
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
G
Ccr5
C-C motif chemokine receptor 5
IEP
protein:increased expression:lung, T-helper cell (mouse)
RGD
PMID:16988274
RGD:4892091
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Clec5a
C-type lectin domain family 5, member a
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 6:40,551,832...40,562,739
Ensembl chr 6:40,551,828...40,562,755
G
Col3a1
collagen, type III, alpha 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col6a1
collagen, type VI, alpha 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
G
Col6a2
collagen, type VI, alpha 2
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
G
Crp
C-reactive protein, pentraxin-related
ISO
RGD
PMID:21426633
RGD:5131292
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Dnase1l3
deoxyribonuclease 1-like 3
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr14:14,475,014...14,504,586
Ensembl chr14:14,475,200...14,505,240
G
Fcer2a
Fc receptor, IgE, low affinity II, alpha polypeptide
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 8:3,730,280...3,744,174
Ensembl chr 8:3,731,737...3,744,175
G
Flt1
FMS-like tyrosine kinase 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Galc
galactosylceramidase
ISO IEP
associated with Guillain-Barre syndrome; protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (mouse)
RGD
PMID:27490360 PMID:29301655 PMID:30396892 PMID:30396892 PMID:12225900
RGD:38599168 , RGD:38599172 , RGD:38599171 , RGD:38599171 , RGD:38599169
NCBI chr12:98,168,543...98,226,565
Ensembl chr12:98,168,553...98,225,718
G
Hdc
histidine decarboxylase
IEP
RGD
PMID:17158962
RGD:5143920
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
G
Htra3
HtrA serine peptidase 3
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 5:35,809,370...35,837,157
Ensembl chr 5:35,809,367...35,837,126
G
Ifng
interferon gamma
IEP
mRNA:increased expression:lung:
RGD
PMID:7935058
RGD:10755754
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il22ra2
interleukin 22 receptor, alpha 2
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr10:19,497,776...19,510,429
Ensembl chr10:19,497,746...19,510,429
G
Inhba
inhibin beta-A
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
G
Ms4a1
membrane-spanning 4-domains, subfamily A, member 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr19:11,227,043...11,243,513
Ensembl chr19:11,227,039...11,243,605
G
Pld4
phospholipase D family member 4
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr12:112,727,089...112,735,420
Ensembl chr12:112,727,089...112,735,424
G
Spib
Spi-B transcription factor (Spi-1/PU.1 related)
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 7:44,175,419...44,181,511
Ensembl chr 7:44,175,417...44,181,495
G
Tcf7
transcription factor 7, T cell specific
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158
G
Tcl1
T cell lymphoma breakpoint 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr12:105,183,012...105,188,996
Ensembl chr12:105,183,009...105,189,052
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf13c
tumor necrosis factor receptor superfamily, member 13c
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr15:82,105,943...82,108,581
Ensembl chr15:82,105,944...82,108,570
G
Aicda
activation-induced cytidine deaminase
IMP
RGD
PMID:26456931
RGD:11098923
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:20231413
RGD:4890435
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Btk
Bruton agammaglobulinemia tyrosine kinase
ameliorates
IMP
RGD
PMID:30646846
RGD:124715470
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
G
C3
complement component 3
disease_progression
IMP ISO
associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion protein:decreased expression:serum
RGD
PMID:15972516 PMID:17956621 PMID:20405
RGD:5129509 , RGD:5129523 , RGD:5130163
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
IMP
RGD
PMID:16455992
RGD:4892130
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Cd14
CD14 antigen
IMP
RGD
PMID:17185649
RGD:4144788
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:10515841
RGD:4892626
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Crhr1
corticotropin releasing hormone receptor 1
IMP
RGD
PMID:21774994
RGD:5147472
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Crhr2
corticotropin releasing hormone receptor 2
IMP
RGD
PMID:21774994
RGD:5147472
NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001
G
Crp
C-reactive protein, pentraxin-related
disease_progression
ISO
RGD
PMID:21281676
RGD:5131293
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20958976
RGD:5134957
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl9
C-X-C motif chemokine ligand 9
IEP
protein:increased expression:lung
RGD
PMID:20381636
RGD:5135285
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Defb3
defensin beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
G
Hc
hemolytic complement
severity
IAGP
RGD
PMID:7814608
RGD:5130159
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hmox1
heme oxygenase 1
IEP
associated with influenza;protein:increased expression:lung
RGD
PMID:17348295
RGD:4145366
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
ISO
RGD
PMID:19396720
RGD:5147385
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Il15
interleukin 15
IEP
protein:increased expression:alveolar macrophage, bronchial epithelial cell
RGD
PMID:17611121
RGD:5000755
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Il15ra
interleukin 15 receptor, alpha chain
IEP
RGD
PMID:17611121
RGD:5000755
NCBI chr 2:11,709,992...11,739,129
Ensembl chr 2:11,710,101...11,739,128
G
Il17a
interleukin 17A
IDA
RGD
PMID:19995896
RGD:4888531
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
IMP
RGD
PMID:15770015
RGD:4889960
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il6
interleukin 6
IDA
RGD
PMID:20643849
RGD:4143255
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Lep
leptin
IMP
RGD
PMID:17822444
RGD:5128869
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
IMP
RGD
PMID:21148797
RGD:5128846
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Mapk1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Masp2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 4:148,679,079...148,699,939
Ensembl chr 4:148,687,011...148,699,956
G
Mbl2
mannose-binding lectin (protein C) 2
no_association
ISO
DNA:polymorphisms:5' utr, exon:multiple (human) DNA:mutations:5' utr, exon:multiple (human)
RGD
PMID:12047967 PMID:18641104
RGD:4889478 , RGD:4889477
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Nos2
nitric oxide synthase 2, inducible
IMP
RGD
PMID:17056580
RGD:4891950
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Pten
phosphatase and tensin homolog
ameliorates
IMP
myeloid knockout
RGD
PMID:20505137
RGD:127285597
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Sftpd
surfactant associated protein D
severity
IMP
RGD
PMID:16255775
RGD:4143519
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Sting1
stimulator of interferon response cGAMP interactor 1
IMP
RGD
PMID:29263110
RGD:39128230
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
G
Tlr2
toll-like receptor 2
IMP
RGD
PMID:19956717
RGD:4145321
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tnf
tumor necrosis factor
IMP IEP
associated with influenza;protein:increased expression:lung
RGD
PMID:9032201 PMID:17348295
RGD:4143479 , RGD:4145366
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IEP IDA
RGD
PMID:24752755 PMID:19596984
RGD:126928121 , RGD:127229903
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Ido1
indoleamine 2,3-dioxygenase 1
IMP
RGD
PMID:20385761
RGD:39938865
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Akt1
thymoma viral proto-oncogene 1
treatment
IMP
RGD
PMID:23613163
RGD:38676477
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Cd86
CD86 antigen
IEP
protein:decreased expression:spleen, plasmacytoid dendritic cell (mouse)
RGD
PMID:20949109
RGD:4892562
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cftr
cystic fibrosis transmembrane conductance regulator
IMP
RGD
PMID:28289144
RGD:36049750
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:10228098
RGD:11039478
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Fn1
fibronectin 1
ISO
RGD
PMID:12065530
RGD:7205474
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Ifnar1
interferon (alpha and beta) receptor 1
susceptibility
IMP
RGD
PMID:19603548
RGD:5490273
NCBI chr16:91,281,016...91,307,411
Ensembl chr16:91,282,126...91,304,329
G
Il10
interleukin 10
IEP
mRNA, protein:increased expression:lung
RGD
PMID:22940620
RGD:7364825
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il15
interleukin 15
IMP
RGD
PMID:18390740
RGD:4996474
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Il1b
interleukin 1 beta
IGI
RGD
PMID:20065029
RGD:4142828
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il33
interleukin 33
IEP
mRNA:increased expression:lung:
RGD
PMID:28401938
RGD:40400699
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Nod2
nucleotide-binding oligomerization domain containing 2
IMP
RGD
PMID:20493961
RGD:5131444
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Prkn
parkin RBR E3 ubiquitin protein ligase
IEP
protein:increased expression:lung (mouse)
RGD
PMID:28663335
RGD:13432209
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
severity
IEP IMP
mRNA:increased expression:lung associated with influenza
RGD
PMID:31782850 PMID:31782850
RGD:39131288 , RGD:39131288
NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
G
Ripk3
receptor-interacting serine-threonine kinase 3
treatment
IEP
RGD
PMID:25445964
RGD:127229910
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
G
Sftpb
surfactant associated protein B
ameliorates
ISO
RGD
PMID:20007532
RGD:151667448
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Atm
ataxia telangiectasia mutated
exacerbates
IMP
RGD
PMID:27421701
RGD:126779562
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Btk
Bruton agammaglobulinemia tyrosine kinase
IMP
RGD
PMID:30873567
RGD:124715473
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
G
Cd209b
CD209b antigen
severity
IMP
RGD
PMID:16134084
RGD:39938986
NCBI chr 8:3,967,655...3,976,841
Ensembl chr 8:3,967,655...3,976,844
G
Ido1
indoleamine 2,3-dioxygenase 1
IEP
mRNA:increased expression:lung (mouse)
RGD
PMID:20385761
RGD:39938865
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifng
interferon gamma
IEP
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il6
interleukin 6
IEP
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak3
interleukin-1 receptor-associated kinase 3
severity
IMP
RGD
PMID:22492852
RGD:35316076
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Itgb2
integrin beta 2
susceptibility
IMP
RGD
PMID:11390487
RGD:127345090
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Lamp1
lysosomal-associated membrane protein 1
IEP
protein:increased expression:lung, natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
G
Marco
macrophage receptor with collagenous structure
exacerbates
IMP
RGD
PMID:15263032
RGD:41412189
NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753
G
Ncr1
natural cytotoxicity triggering receptor 1
severity
IMP
RGD
PMID:21887255
RGD:40818252
NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163
G
Pdcd1
programmed cell death 1
treatment
IMP
RGD
PMID:25624454
RGD:40818422
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
treatment
IMP
associated with immunodeficiency 14
RGD
PMID:30093657
RGD:40890269
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
severity
IMP
RGD
PMID:17322108
RGD:38599154
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Ripk3
receptor-interacting serine-threonine kinase 3
exacerbates
IMP
RGD
PMID:33625952
RGD:127229925
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
G
Tnf
tumor necrosis factor
IEP
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all